Narrow Results

BAYER HealthCare and Economic Development Board to foster translational and clinical research for diseases prevalent in Asia

Ludwig Cancer Research and University of Oxford launch Cancer Immunotherapy Spinout

OmniComm Systems® Announces Reseller Agreement with Tri-I Biotech Shanghai Inc. Market Leading Life Sciences Consultancy to Resell OmniComm’s TrialOne® eSource Solution

Resverlogix Closes License Agreement and Enters Into Definitive Stock Purchase Agreement with Hepalink

Immunovaccine and PharmAthene Sign Exclusive Worldwide License Agreement to Develop and Commercialize an Anthrax Vaccine Formulated in DepoVax™

Commonwealth Financing Authority Announces New Alternative, Clean Energy Investment

ContraFect Corporation Announces Issuance of Key Patent Covering Novel Lysin Technology

M Pharmaceutical Inc. Rebrands Itself to Better Reflect Growing Family of Biomedical Technologies

Sustainable Apparel Coalition Recognizes SCS Global Services as Approved Verifier for New Pilot Program

StemCell United Announces Plans for PO and Listing on ASX

Roche Diagnostics Strengthens Footprint in Asia Pacific

I intend to set down here some details of my interaction with these remarkable men and women. Since their scientific merits are well known, I need not discuss them here but shall restrict myself as far as possible to my own personal interaction with them. In the first place, I wish to stress that I have never “collected” Nobel Prize winners, never tried to contact scientists simply because they were already in this elevated category. With one or two exceptions, the scientists I mention in these pages had not yet made the journey to Stockholm at the time I became acquainted with them. Rather, it seems that throughout my career I have had the good fortune to have had contact with people who were destined to make important contributions to the progress of science. Lucky Jack!